What Gentech does

Gentech Diagnostics is a CLIA-certified reference laboratory headquartered at 4403 N Beltwood Pkwy in Dallas, Texas. The company operates as a B2B reference lab, processing clinical specimens submitted by healthcare providers rather than performing direct patient testing. It is licensed in Texas, California, and Arizona, and serves healthcare providers across more than 40 major metropolitan areas via overnight specimen courier logistics routed to its single Dallas facility. Gentech maintains CLIA, CAP, COLA, SAMHSA, HIPAA, and DOT 49 CFR Part 40 certifications, and is enrolled as a Medicare and Medicaid provider.

The company's core product platform consists of three lines: molecular diagnostics (multiplex PCR respiratory panels detecting COVID-19, Influenza A/B, RSV, and expanded pathogens), toxicology testing (urine, blood, hair, oral fluid with GC/MS and LC-MS/MS confirmation), and workplace drug testing (DOT and non-DOT programs). Specialized modules include pain management compliance panels, synthetic opioid detection (fentanyl and fentanyl analogs), and a comprehensive drug screen covering 20+ drug classes. Methodological differentiators are confirmation-grade mass spectrometry and a >97% sensitivity SARS-CoV-2 RT-PCR assay. Results are delivered electronically through HL7 EHR integration and a HIPAA-compliant LIS portal.

Gentech monetizes through per-specimen reference lab services billed to healthcare providers, insurance payors, and government programs (Medicare/Medicaid). Pricing is quote-based and not publicly disclosed. Customer segments include hospitals and health systems (Baylor Scott & White, CHRISTUS Spohn, Sharp, Scripps, Banner, Texas Tech HSC), physician practices, pain management clinics, pediatric/urgent care, occupational health clinics, and DOT-regulated employers. GTM is sales-led via direct provider outreach, account setup with EHR integration, and professional referral channels. No funding rounds, M&A, partnerships, or leadership changes are disclosed in the input data.

Name

Gentech

Legal name

Gentech Diagnostics

Website

https://gentechdiagnostics.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

101–250 employees

Short description

Gentech Diagnostics is a CLIA-certified reference laboratory in Dallas, TX providing molecular diagnostics, toxicology, and workplace drug testing to healthcare providers, employers, and pain management practices across Texas, California, and Arizona.

Ownership category

akta.pro rank

Product category

Clinical Reference Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)

akta.pro secondary industries

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

• Clinical laboratory services
• Molecular diagnostics
• Toxicology testing
• Drug screening
• Respiratory PCR testing

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Laboratory Testing Services: Reference laboratory providing sample processing and analysis services to healthcare providers. Revenue generated from processing clinical specimens for diagnostic testing including molecular, toxicology, and drug testing services. Services billed to healthcare providers, insurance companies, and government programs (Medicare/Medicaid).

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Gentech Diagnostics operates a CLIA-certified, CAP-accredited reference laboratory in Dallas, TX that processes specimens submitted by healthcare providers, clinics, and authorized employers across Texas, California, and Arizona. Core laboratory services include molecular diagnostics (multiplex respiratory PCR panels for COVID-19, Influenza A/B, RSV), clinical and forensic toxicology with GC/MS and LC-MS/MS confirmation, and workplace/drug screening programs including DOT-compliant urine, oral fluid, and hair follicle testing. Results are delivered electronically via HL7 EHR integration or a HIPAA-compliant LIS portal, with most results returned in 24-48 hours.

Product overview

Gentech Diagnostics operates as a CLIA-certified reference laboratory offering a comprehensive diagnostic testing platform. The core offering consists of Molecular Testing and Toxicology Testing services, supported by specialized modules including Respiratory PCR Testing (with COVID-19, Influenza, and RSV multiplex panels), Workplace Drug Testing (DOT and non-DOT programs), and Pain Management Toxicology Panels. The laboratory employs advanced methodologies including GC/MS and LC-MS/MS confirmation for clinical and forensic applications, serving healthcare providers across Texas, California, and Arizona. Results are delivered electronically via HL7 integration with EHR systems and through a HIPAA-compliant LIS portal.

Differentiator

Problem solved

Functional benefit

Products and services

• Molecular Testing Specialized laboratory tests using molecular diagnostic techniques, covering pathogen detection including multiplex respiratory pathogen panels. Designed for healthcare providers and clinical decision-making.
• Toxicology Testing Advanced clinical and forensic toxicology testing with GC/MS and LC-MS/MS confirmation, professional analysis, and interpretation. Targeted at healthcare providers, pain management practices, and forensic applications.
• Respiratory PCR Testing CLIA-certified multiplex PCR molecular diagnostics for respiratory pathogens, detecting COVID-19, Influenza A/B, and RSV simultaneously from a single specimen, with expanded panels covering parainfluenza, adenovirus, rhinovirus, and bacterial pathogens. Designed for hospitals, pediatric practices, urgent care, and long-term care facilities.
• Workplace Drug Testing Comprehensive drug testing program for employers covering DOT and non-DOT requirements across urine, hair follicle, oral fluid, and blood specimen types, with SAMHSA-certified collection protocols and Medical Review Officer (MRO) services. Targeted at DOT-regulated employers and occupational health programs.
• Pain Management Toxicology Panel Specialized urine toxicology panels for monitoring medication compliance in chronic pain management patients. Detects prescribed opioids, benzodiazepines, and illicit substances with quantitative levels for compliance assessment and includes synthetic opioid detection. Designed for pain management physicians and addiction medicine specialists.
• Oral Fluid Testing Non-invasive drug testing using oral fluid samples for recent drug use detection with a 24-48 hour window. Collection method DOT-approved, observed collection eliminates adulteration risk. Targeted at employers and occupational health programs.
• Hair Follicle Testing Drug detection over the prior 90 days using 1.5 inches of head hair. Resistant to adulteration, used for executive screening and custody disputes. Targeted at employers, legal/custody contexts, and court-admissible testing needs.
• DOT Compliance Testing Federally-mandated drug and alcohol testing program for safety-sensitive transportation workers including CDL drivers, transit, aviation, rail, pipeline, and maritime employees under 49 CFR Part 40. SAMHSA-certified panel with complete MRO services. Targeted at DOT-regulated employers.
• Synthetic Opioid Detection Testing service that detects fentanyl, fentanyl analogs including carfentanil and acetylfentanyl, and emerging synthetic opioids. Used for overdose surveillance, harm reduction, and clinical toxicology decision support. Targeted at hospitals, pain management practices, and public health surveillance programs.
• Comprehensive Drug Screen (CDS) Broad-spectrum toxicology screen covering 20+ drug classes including prescription medications, illicit substances, and synthetic analogs. Used for complex clinical toxicology cases, pain management, and treatment planning. Targeted at healthcare providers managing complex patient toxicology cases.

Quantifiable outcome

• 24-48 hour turnaround for respiratory PCR results
• +2 more outcomes

Named customers18 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature5 records

Scale indicators3 records

Recent moves3 records

Expansion highlights4 records

Direct peers

• Millennium Health: National specialty toxicology laboratory focused on drug confirmation testing, medication monitoring, and pain management panels using LC-MS/MS — directly comparable to Gentech's core toxicology and pain management offerings and similar customer base of providers and pain practices.
• BioReference Laboratories (OPKO Health): Specialty and routine clinical reference laboratory with significant molecular diagnostics and women's health testing, serving providers and health systems; comparable in offering multiplex molecular panels to hospital clients.
• Ethos Laboratories: Specialty clinical laboratory providing toxicology, pain management, addiction medicine, and pharmacogenomics testing using LC-MS/MS — comparable niche focus and provider customer base, with a similar multi-test menu approach.
• Dominion Diagnostics: Clinical toxicology reference laboratory offering medication monitoring, addiction medicine, and pain management panels with quantitative LC-MS/MS — closely comparable service mix and target customer (pain and behavioral health providers) as Gentech.
• Precision Toxicology: Specialty pain management and clinical toxicology reference laboratory providing quantitative urine drug confirmation panels to pain practices, addiction specialists, and primary care — closely comparable niche operator.
• Avero Diagnostics: Specialty toxicology and clinical reference laboratory offering urine drug confirmation, quantitative LC-MS/MS, and pain management panels — similar mid-sized independent competitor serving pain and addiction medicine providers.
• Cordant Health Solutions: Specialty toxicology and medication-monitoring laboratory providing urine drug confirmation, oral fluid, and pain management testing to providers and employers — overlapping menu, methodology (LC-MS/MS), and customer segment with Gentech.

Broad incumbents

• Laboratory Corporation of America (Labcorp): National full-service clinical reference laboratory with broad toxicology, molecular diagnostics, and workplace drug testing capabilities — the other dominant incumbent competing for the same hospital and health system customers.
• ARUP Laboratories: Hospital-affiliated national reference laboratory providing esoteric and routine clinical testing, including molecular diagnostics and toxicology, to large health systems and academic medical centers — a relevant peer for the academic and IDN customer overlap.
• Quest Diagnostics: One of the two largest U.S. clinical reference laboratories, providing a full-service menu including toxicology, molecular, and workplace drug testing; represents the dominant incumbent Gentech competes against for hospital and employer contracts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Gentech-Diagnostics-111124924793979
• LinkedInlinkedin.com/company/gentechdiagnostics

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gentech